.Collection Biosciences is carrying on up. The tissue therapy firm has actually added on $325 millio...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...
.Aelis Farma's chances of securing a fast, beneficial choice on a $one hundred thousand possibility ...
.ProKidney has stopped one of a set of period 3 tests for its cell therapy for renal ailment after d...
.Vaxcyte unveiled what analysts referred to as "sensational" phase 1/2 data for its own 31-valent pn...
.Recursion has stumbled with a very early test of its tech-enabled strategy to medication exploratio...
.Contact it a case of excellent chemistry: Acepodia, a biotech based upon Nobel Champion science, is...
.Practice Preciseness Medicines has racked up one more midphase succeed in epilepsy this year, with ...
.After leaving a clinical hold a number of years back, Dyne Rehab has shown brand new phase 1/2 data...
.Arrowhead Pharmaceuticals has actually presented its own give in advance of a potential showdown wi...